Regulatory agencies like the FDA and the European Medicines Agency (EMA) have stringent guidelines for the safety evaluation of APIs. These agencies require comprehensive toxicological studies, including animal testing, before an API can progress to human trials. The results of these studies are critical for securing approval for clinical trials and eventual marketing of the drug.
